Host N-Glycosylation Supports EPEC Attachment and Effector Delivery

October 30, 2026

Disrupting host N-glycan maturation weakens enteropathogenic Escherichia coli infection at two stages: attachment and effector delivery. Experiments that separate these steps show that the translocation defect cannot be explained by reduced adhesion alone.

Introduction

Enteropathogenic Escherichia coli (EPEC) causes pediatric diarrhea, yet the host factors that determine whether the bacterium gains a foothold in the intestine are still being mapped. A Cell Reports study uses two genome-scale CRISPR screens in human cells, one based on bacterial toxicity and one on Tir translocation, to identify host factors that support infection. The results implicate N-linked poly-N-acetyllactosamine (poly-LacNAc) in initial attachment, while N-glycan maturation also supports later effector delivery through an attachment-independent mechanism.

The screens identified genes involved in N-glycan maturation and poly-LacNAc synthesis. B3GNT2 ranked among the top hits in both screens; MGAT1, SLC35A2, and TMEM165 were prominent in the toxicity screen, while MGAT2 and MGAT5 were additional hits outside its top 20. These results prioritize a pathway, rather than independently validating every gene. N-Glycan Profiling can complement functional genetics by characterizing the resulting glycan changes.

Two Screens Converge on LacNAc Biosynthesis

The toxicity screen infected mutagenized HT-29 colorectal adenocarcinoma cells with a hypertoxic EPEC/pMgrR strain and recovered genes whose disruption favored cell survival. The translocation screen used K562 cells infected with an intimin-deficient EPEC strain. GFP-expressing E. coli K12 bearing intimin then labeled cells displaying translocated Tir, allowing fluorescence-based sorting. Both assays identified glycosylation-related hits, and B3GNT2, which contributes to poly-LacNAc synthesis, ranked among the top hits in both.

Two genome-scale CRISPR-Cas9 screens identify host N-glycosylation and LacNAc biosynthesis as required for EPEC infection.

Fig. 1 Genome-wide CRISPR-Cas9 screens identify host N-glycosylation as required for EPEC infection. (Cohen Yaron, et al., 2026)

MGAT1 Loss Reduces Cytotoxicity and Reshapes Surface Glycans

To validate the pathway, the team knocked out MGAT1 in HeLa cells. Its protein product adds GlcNAc to mannose during N-glycan maturation, a prerequisite for generating the complex structures examined here. After infection with hypertoxic EPEC/pMgrR, MGAT1-deficient cells showed approximately 35% cytotoxicity compared with approximately 70% in wild-type cells. Flow cytometry showed increased concanavalin A binding and reduced wheat germ agglutinin staining, consistent with altered surface glycan presentation. These lectin readouts complement Glycan Profiling, but do not alone resolve the complete surface glycome.

The results show that disrupting a host glycosylation pathway changes susceptibility under the tested infection conditions. They also underscore why measuring surface glycan presentation, alongside gene expression, matters. Methods such as Lectin Microarray Assay can provide complementary glycan-binding profiles, although the paper used lectin flow cytometry and microscopy rather than a lectin microarray.

Surface LacNAc Supports BFP-Mediated Attachment

The most concrete mechanistic insight concerns attachment. EPEC uses a bundle-forming pilus to adhere before injecting effectors through its type III secretion system. MGAT1 knockout cells showed sharply reduced early microcolony attachment that was restored by re-expressing MGAT1, and a type III secretion-deficient mutant, which can attach only via the pilus, remained poorly attached even at later times. Adding soluble LacNAc mimicked the knockout phenotype, inhibiting wild-type attachment to the level seen without surface LacNAc. Together these results argue that terminal LacNAc on host N-glycans serves as the pilus receptor, supporting earlier suggestions from the literature.

EPEC microcolony attachment to wild-type and MGAT1-knockout HeLa cells, including inhibition by soluble LacNAc.

Fig. 2 Reduced EPEC attachment to MGAT1-knockout cells lacking surface LacNAc. (Cohen Yaron, et al., 2026)

A Dual Role for Host Glycosylation

Host N-glycosylation supported infection through attachment-dependent and attachment-independent mechanisms. An EPEC mutant lacking both bundle-forming pili and type I fimbriae bound at similarly low levels to wild-type and MGAT1-knockout cells, yet effector delivery remained reduced in the knockout cells. This experiment supports a translocation defect beyond reduced attachment. Separately, a BFP-deficient, type I fimbria-ON variant showed enhanced attachment to mannose-exposing knockout cells. Such adhesin-dependent differences motivate complementary Lectin-based Technologies for Glycan Profiling and Glycoprotein Microarray Assay studies, followed by validation in infection models.

Experiments in two-dimensional monolayers derived from human colon and jejunum organoids added tissue context. EPEC microcolonies preferentially associated with cells showing low ConA staining, and high-ConA cells were more abundant in colon-derived monolayers. This supports an association between surface glycan presentation and attachment, without establishing the full glycan structures or proving the cause of intestinal tissue tropism.

Implications for Anti-Virulence Strategy

The attachment experiments support further investigation of glycan-based anti-adhesion approaches. Soluble LacNAc inhibited attachment in the tested cell system, but the study did not establish clinical efficacy, the safety of modifying host glycosylation, or reduced selection for resistance. It also did not validate glycosylation state as a clinical susceptibility biomarker.

Characterizing the relevant structures could draw on Glycomic Characterization Service workflows. Glycomics measures glycan structures, whereas site-specific glycoproteomics is needed to connect modifications to individual peptide sites. The surface-proteomic analysis in this study measured changes in membrane-associated proteins; it did not identify a single glycosylated receptor responsible for the attachment-independent translocation defect.

Host Genotype, Tissue Glycome, and Infection Susceptibility

The screens identify host genes for mechanistic follow-up, but do not establish that naturally occurring variants change patients' infection risk. The study did not genotype patients or test associations with diarrheal disease outcomes. Future work could examine whether epithelial glycan profiles or variation in the implicated pathways are associated with susceptibility, using appropriate clinical cohorts.

The organoid-derived monolayers add a spatial dimension to the findings. Colon- and jejunum-derived cultures differed in ConA staining, with EPEC microcolonies favoring low-ConA cells. Because ConA reports accessible mannose-containing motifs, it provides an indirect comparison of glycan presentation rather than a complete map of LacNAc structures. The results suggest that tissue glycosylation may contribute to tropism, alongside other host and microbial factors.

This tissue context also matters when designing anti-adhesion studies. Candidate glycans or inhibitors should be assessed in relevant epithelial models, and glycan presentation should be measured alongside bacterial attachment and effector delivery. The organoid-derived monolayers provide a useful model, while remaining simpler than the intact intestinal environment.

Outlook

The LacNAc receptor model is supported by the attachment experiments, while the host factors connecting N-glycan maturation to attachment-independent T3SS activity remain unresolved. The paper links this defect to broad changes in the surface proteome, but does not identify the decisive factor. Further testing of anti-adhesion strategies will also need to address host safety and the limitations of available EPEC infection models.

For glycoscience, the paper shows how functional genomics, glycan-sensitive assays, and infection experiments can distinguish receptor-dependent attachment from additional host requirements for effector delivery.

Related Services & Products

Reference

  1. Cohen Yaron, K., et al. (2026). Dual roles of host N-glycosylation in enteropathogenic Escherichia coli infection. Cell Reports, 45, 118043. DOI: 10.1016/j.celrep.2026.118043.

Similar Posts